Hyloris Pharmaceuticals S.A.
HYL.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €24 | €30 | €43 | €50 |
| Short-Term Investments | €1 | €0 | €0 | €1 |
| Receivables | €5 | €4 | €4 | €2 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €1 | €1 | €2 | €1 |
| Total Curr. Assets | €30 | €35 | €50 | €54 |
| Property Plant & Equip (Net) | €2 | €2 | €1 | €0 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €4 | €4 | €4 | €3 |
| Long-Term Investments | €4 | €5 | €4 | €4 |
| Tax Assets | €0 | €0 | -€4 | €1 |
| Other NC Assets | €2 | €2 | €6 | €2 |
| Total NC Assets | €12 | €12 | €11 | €9 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €41 | €48 | €62 | €63 |
| Liabilities | – | – | – | – |
| Payables | €3 | €3 | €2 | €3 |
| Short-Term Debt | €0 | €0 | €3 | €12 |
| Tax Payable | €0 | €0 | €0 | €0 |
| Deferred Revenue | €0 | €0 | €0 | €0 |
| Other Curr. Liab. | €3 | €3 | €0 | €0 |
| Total Curr. Liab. | €7 | €7 | €6 | €15 |
| LT Debt | €1 | €2 | €1 | €0 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €1 | €0 | €0 | €0 |
| Total NC Liab. | €2 | €2 | €1 | €0 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €2 | €2 | €1 | €0 |
| Total Liabilities | €9 | €9 | €7 | €15 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €2 | €1 |
| Common Stock | €0 | €0 | €0 | €0 |
| Retained Earnings | -€86 | -€81 | -€65 | -€55 |
| AOCI | -€4 | -€2 | -€2 | -€1 |
| Other Equity | €122 | €122 | €119 | €103 |
| Total Equity | €32 | €39 | €54 | €48 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €41 | €48 | €62 | €63 |
| Net Debt | -€22 | -€29 | -€39 | -€38 |